Original Research
Published on 04 Oct 2022
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
in Cancer Immunity and Immunotherapy

- 2,885 views
- 4 citations
Original Research
Published on 04 Oct 2022
in Cancer Immunity and Immunotherapy

Mini Review
Published on 04 Oct 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 03 Oct 2022
in Cancer Immunity and Immunotherapy

Correction
Published on 03 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 03 Oct 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 03 Oct 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 30 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 30 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 30 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 30 Sep 2022
in Cancer Immunity and Immunotherapy

Editorial
Published on 30 Sep 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 29 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 29 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 29 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 29 Sep 2022
in Cancer Immunity and Immunotherapy
